Christopher Stone

Christopher Stone

Vorstandsvorsitzender bei PDL BIOPHARMA, INC.
61 Jahre
Health Technology
Consumer Services
Commercial Services

Profil

Christopher Lewis Stone currently works at PDL BioPharma, Inc., as CEO, Secretary, Director & General Counsel, The District of Columbia Bar, as Member, Nevada Bar Association, as Member, and The State Bar of California, as Member.
Mr. Stone also formerly worked at Noden Pharma USA, Inc., as Secretary & Director, Genencor International, Inc., as VP-Intellectual Property & General Patent Counsel from 1994 to 2005, International N&H Denmark ApS, as Vice President-Intellectual Assets USA from 2005 to 2006, LS Dissolution, Inc., as Secretary & Vice President-Legal Affairs, and Willian Brinks Hofer Gilson & Lione Ltd., as Associate Attorney.
Mr. Stone received his undergraduate degree from the University of Massachusetts and graduate degree from George Washington University Law School.

Aktive Positionen von Christopher Stone

UnternehmenPositionBeginn
PDL BIOPHARMA, INC. Vorstandsvorsitzender 15.05.2021
Corporate Officer/Principal -
Corporate Officer/Principal -
Nevada Bar Association
Corporate Officer/Principal -

Ehemalige bekannte Positionen von Christopher Stone

UnternehmenPositionEnde
Corporate Officer/Principal 01.01.2006
General Counsel 01.01.2005
Direktor/Vorstandsmitglied -
General Counsel -
Willian Brinks Hofer Gilson & Lione Ltd.
Corporate Officer/Principal -
Sehen Sie sich die Erfahrung von Christopher Stone im Detail an

Ausbildung von Christopher Stone

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

80

Beziehungen ersten Grades

11

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen11

Health Technology

Consumer Non-Durables

Consumer Services

Health Technology

Commercial Services

Nevada Bar Association

Commercial Services

Process Industries

Willian Brinks Hofer Gilson & Lione Ltd.

Consumer Services

Electronic Technology

  1. Börse
  2. Insiders
  3. Christopher Stone